Summary
Nonspecific uptake of radiolabeled monoclonal antibodies in normal tissues is a significant problem for tumor imaging. A potential means of decreasing nonspecific antibody binding is to “blockade” nonspecific antibody binding sites by predosing with cold, nonspecific isotypematched antibody, before injecting specific antibody. Nontumor-specific murine monoclonal antibody LK2H10 (IgG1) or Ab-1 (IgG2a) was given i.v. at doses of 0 to 3.5 mg to nude mice with xenografts of human melanoma. These mice were then given i.v. 4 μg of 131I anti-high molecular weight antigen of melanoma (HMWMAA) monoclonal antibody 763.24T (IgG1) or 225.28S (IgG2a), respectively. These mice were also given a tracer dose of 125I LK2H10 or Ab-1, respectively. Specific tumor uptake of anti-HMWMAA antibodies was see in all cases. No drop in tumor or nontumor uptake was demonstrated for either of the tumor-specific or nonspecific monoclonal antibodies due to nonspecific monoclonal antibody pretreatment. These data suggest that high doses of isotype-matched unlabeled nonspecific monoclonal antibody given before 131I tumor-specific monoclonal antibody, will not enhance tumor imaging.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buraggi GL, Callegaro L, Mariani G et al. (1985) Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and tis F(ab')2 fragments. Cancer Res 45(7):3378
Clarkson SB, Bussel JB, Kimberly RP et al. (1986) Treatment of refractory immune thrombocytopenic purpura with an anti-Fc receptor antibody. N Engl J Med 314(19):1236
Colcher D, Zalutsky M, Kaplan W et al. (1983) Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43:736
Ey P, Prowse S, Jenkins C (1978) Isolation of pure IgG1, IgG2a, and IgG2b from mouse serum using protein A-sepharose. Immunochemistry 15:429
Giacomini P, Veglia F, Cordiali-Fei P et al. (1984) Level of membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res 44(3):1281
Ghose T, Ferrone S, Imia K et al. (1982) Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody. J Natl Cancer Inst 69:823
Halpern SE, Buchegger F, Schreyer M, Mach J-P (1984) Effect of size of radiolabeled antibody and fragements on tumor uptake and distribution in nephrectomized mice. J Nucl Med 25(5):112
Imbach P, Barandun S, d'Apuzzo V et al. (1981) High-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet I:1228
Laemmli VK (1970) Cleavage of structural proteins during assembly of the head bacteriophage T4. Nature 222:680
Lindmo T, Boven E, Cuttitta F, et al. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77
Otsuka FL, Welch MJ (1986) Attempts to saturate the hepatic clearance mechanism for (In-111) labeled monoclonal antibodies. J Nucl Med 27(6):921
Parham P (1983) On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol 131(6):2895
Pierce Chemical Product Guide, Pierce Chemical, Rockford, Ill., USA
Shah SA, Pollock RR, Brown BA et al. (1986) Pharmacokinetics and imaging using mutant monoclonal anti-ARS antibodies. Proc of AACR 27:335
Siccardi AG, Buraggi GL, Callegaro L et al. (1986) Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res 46(9):4817
Stauss HW, Carrasquillo JA, Larson SM (1985) Antibody imaging: The smoke, the fire and the false alarm. Int J Nucl Med Biol 12(5):401
Wahl RL, Parker CW, Philpott GW (1983) Improved radio-imaging and tumor localization with monoclonal F(ab')2. J Nucl Med 24:316
Wahl RL, Philpott GW, Parker CW (1983) Monoclonal antibody radioimmunodetection of human-derived colon cancer. Invest Rad 18:58
Wahl RL, Sherman P, Fisher S (1984) The effect of specimen processing on radiolabeled monoclonal antibody biodistribution. Eur J Nucl Med 9(8):382
Wahl RL, Liebert M, Carey JE, et al. (1986) Quality control of radiolabeled monoclonal antibodies: Immunologic and radiochemical. Cancer Drug Deliv 2(3):236
Wilson BS, Lloyd RV (1984) Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 115:458
Wilson BS, Imai K, Natali PG, Ferrone S (1981) Distribution and molecular characterization of a cell surface and cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 28:293
Wilson BS, Platt JL, Kay NE (1985) Monoclonal antibodies to the 140,000 mol at glycoprotein B-lymphocyte membranes (CR2 receptor) initiates proliferation of B-cells in vitro. Blood 66(4):824
Author information
Authors and Affiliations
Additional information
Present address: Hybritech, San Diego, CA, USA
Rights and permissions
About this article
Cite this article
Wahl, R.L., Wilson, B.S., Liebert, M. et al. High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts. Cancer Immunol Immunother 24, 221–224 (1987). https://doi.org/10.1007/BF00205633
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205633